1 active not recruiting, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Neurotrophic Ulcer: new trials by email Literature Review of Neurotrophic Ulcer trials Research Report on Neurotrophic Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Serum Obtained by a Closed-Circuit Collection Device Autologous Serum 20% - GVHD, Meibomian Gland Dysfunction (Disorder) | Phase 2 | Active not recruiting | GIANCARLO FATOBENE | 16 | 2025-06-20 | 2026-10-21 |
| OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate Cenegermin-Bkbj 0.002% Ophthalmic Solution [OXERVATE] - Neurotrophic Ulcer, Neurotrophic Keratitis | Unknown | Sight Medical Doctors PLLC | 10 | 2020-10-01 | 2024-04-17 |
Graft vs Host Disease (1) · Meibomian Gland Dysfunction (1) · Stevens-Johnson Syndrome (1)
Chemically-Induced Disorders (1) · Dermatitis (1) · Drug Eruptions (1) · Drug Hypersensitivity (1) · Drug-Related Side Effects and Adverse Reactions (1) · Erythema (1) · Erythema Multiforme (1) · Eye Diseases (1) · Eyelid Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Delayed (1) · Immune System Diseases (1) · Mouth Diseases (1) · Skin Diseases (1) · Skin Diseases, Vesiculobullous (1)
Ophthalmic Solutions (1) · cenegermin (1)
GIANCARLO FATOBENE (1) · Sight Medical Doctors PLLC (1)
Brazil (1) · United States (1)
Brad Kligman, MD (1)